CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
about
Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degenerationStructural and biochemical characterization of CRN-5 and Rrp46: An exosome component participating in apoptotic DNA degradationAn unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactionsThe sentinel within: exploiting the immune system for cancer biomarkers.Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia veraA novel unconventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia veraA human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.The exozyme model: a continuum of functionally distinct complexes.An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.The exosome controls alternative splicing by mediating the gene expression and assembly of the spliceosome complex.A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L.The Role of Immunogenicity in Cardiovascular Disease.Genome-wide mRNA surveillance is coupled to mRNA export.Processing sites are different in the generation of HLA-A2.1-restricted, T cell reactive tumor antigen epitopes and viral epitopes.Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.
P2860
Q24613553-95CEA36C-D564-482E-8A07-BF9DD558A13DQ27663607-B7CE2503-87F0-49CF-80F3-002CD9FE35C4Q28264336-CA312FF2-58DD-49A2-AF58-E9BD65E474D6Q33221191-9F3822DE-82F7-4CA8-BEE1-E71FB4D64F0DQ33264010-6DA89C94-86BF-4748-A7AC-38D4B0126D00Q33290521-63133B38-F87F-44AD-8E4D-A1E752FF897EQ33492227-9E18AB54-C9C9-48BD-9AE4-6E1EC15AFF71Q33499385-288D008E-D993-4FC0-A5AD-22DB5486D6C6Q34024670-FF654C17-8270-4C2F-BE99-75236DAF72EFQ35769842-9EDEA2D2-876A-413A-8CD0-F2740F984733Q35996334-EFE64B88-1201-4601-B4CA-CE6405DF8939Q37515426-DD5319C2-AAA4-41AF-AA10-2A220C0173D4Q37560012-7E2FF3A9-3455-4167-9B8A-F8554F80F457Q37598853-DECD928D-9DED-4B80-A9D7-519E6774724BQ38306558-8229F6CA-0516-4E2B-8E8C-6029721FBA74Q39243052-82D4966F-937F-4FDB-B064-3987EBE40109
P2860
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
@ast
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
@en
type
label
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
@ast
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
@en
prefLabel
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
@ast
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
@en
P2093
P2860
P1433
P1476
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells
@en
P2093
Catherine J Wu
Christine Canning
Edwin P Alyea
Glenn Dranoff
Jerome Ritz
Linyun Chen
Philip Kantoff
Robert J Soiffer
Xiao-Feng Yang
P2860
P304
P407
P577
2002-10-01T00:00:00Z